CT
HBIO icon

Colonial Trust’s Harvard Bioscience HBIO Stock Holding History

Colonial Trust’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-121
Closed -$2.44K – 1198
2024
Q4 		$2.44K Hold
121
– – ﹤0.01% 1191
2024
Q3 		$3.29K Buy
121
+26
+27% +$766 ﹤0.01% 943
2024
Q2 		$2.77K Hold
95
– – ﹤0.01% 913
2024
Q1 		$4.01K Hold
95
– – ﹤0.01% 851
2023
Q4 		$5.16K Hold
95
– – ﹤0.01% 794
2023
Q3 		$4.2K Hold
95
– – ﹤0.01% 810
2023
Q2 		$5.33K Sell
95
-29
-23% -$1.59K ﹤0.01% 775
2023
Q1 		$5.22K Hold
124
– – ﹤0.01% 748
2022
Q4 		$3.16K Buy
+124
New +$3.06K ﹤0.01% 816

Other funds holding HBIO

AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Colonial Trust's HBIO Position: Q1 2025 in Review

Colonial Trust sold out of Harvard Bioscience (HBIO) in Q1 2025, closing a stake of 121 shares — an estimated $2.44K sold.

Colonial Trust first reported a position in HBIO in Q4 2022 and held it in 9 quarters. The position peaked at $5.33K in Q2 2023. 91 funds tracked by Wall St. Rank hold HBIO as of Q1 2025.

  • Colonial Trust reported no remaining Harvard Bioscience position as of Q1 2025 after selling out during the quarter.
  • Colonial Trust sold 121 Harvard Bioscience shares in Q1 2025, an estimated $2.44K.
  • Colonial Trust first reported a position in Harvard Bioscience in Q4 2022 and held it in 9 quarters.
  • Colonial Trust's Harvard Bioscience position peaked at $5.33K in Q2 2023.
  • 91 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2025.

Based on Colonial Trust's 13F filing for Q1 2025, filed 14 May 2025.